[1]
“Defining invasive fungal infection risk in hematological malignancies: a new tool for clinical practice”, Mediterr J Hematol Infect Dis, vol. 9, no. 1, p. e2017012, Jan. 2017, doi: 10.4084/mjhid.2017.012.